Skip to content

Effect of Bright Light on Sex Hormones and Ovulation in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00327366
Enrollment
27
Registered
2006-05-18
Start date
2003-09-30
Completion date
2006-04-30
Last updated
2009-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anovulation

Keywords

Menstrual Cycle, Light Therapy, Sex Hormones, Ovulation

Brief summary

The study investigated whether bright artificial light may influence menstrual cycle and ovulation conclusively, and what underlying hormonal changes for this effect are.

Detailed description

Several studies have shown a shortening of the menstrual cycle following light therapy in women with abnormally long menstrual cycles or with winter depression, which suggests that bright light may influence sex hormones and ovulation. The study was designed to investigate this possibility. Twenty-two women with slightly lengthened menstrual cycles and without clinically evident endocrine abnormalities completed a study lasting for two menstrual cycles separated by an off-protocol episode of at least 1 menstrual cycle. Bright light therapy was administered for a week at home during one experimental cycle, and dim light during another cycle (placebo-controlled, crossover, counter-balanced order). Daytime blood sampling and ultrasound scan were performed before and after a week of light therapy, on the \ 7th and 14th days after menstruation onset. Ultrasound examination was repeated further to document ovulation. Serum was assayed for thyroid-stimulating hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol. The preliminary results were reported at the SLTBR meeting in June, 2005.

Interventions

PROCEDURELight therapy

Sponsors

Russian Academy of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 19-40 years * Mean menstrual cycle 28-38 days * Good general health * Generally normal sleep-wake regimen * Motivated for free participation

Exclusion criteria

* Low cooperation * Medications known to interfere with hormone release * Clinically evident endocrine abnormalities including the signs of * Hyperandrogenism * Travel over several time zones during two months prior the study

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026